Urology
Volume 68, Issue 3, Supplement , Pages 17-25 , September 2006

Erection hardness: A unifying factor for defining response in the treatment of erectile dysfunction

  • John P. Mulhall

      Affiliations

    • Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA, and Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    • John P. Mulhall receives research support from Pfizer Inc.
    • Corresponding Author InformationReprint requests: John P. Mulhall, MD, Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital and Memorial Sloan-Kettering Cancer Center, 525 East 68th Street, New York, NY 10021.
    • ,
  • Laurence A. Levine

      Affiliations

    • Rush University Medical Center, Chicago, Illinois, USA
    • Laurence A. Levine is a paid consultant to, member of the Speakers’ Bureau for, and member of the medical advisory board for, Pfizer Inc.
    • ,
  • Klaus-Peter Jünemann

      Affiliations

    • Klinikum der Christian-Albrechts-Universität, Kiel, Germany.

References 

  1. Laumann EO , Nicolosi A , Glasser DB , et al.   Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors . Int J Impot Res . 2005;17:39–57
  2. Feldman HA , Goldstein I , Hatzichristou DG , et al.   Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study . J Urol . 1994;151:54–61
  3. Carson CC , West SL , Glasser DB , et al.   Prevalence and correlates of erectile dysfunction in a United States nationwide population-based sample: phase I results . [abstract] J Urol . 2002;167(suppl):29–30
  4. Carson CC , Burnett AL , Levine LA , et al.   The efficacy of sildenafil citrate (Viagra) in clinical populations: an update . Urology . 2002;60(suppl 2B):12–27
  5. Rosen RC , Riley A , Wagner G , et al.   The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction . Urology . 1997;49:822–830
  6. Rosen RC , Althof SE , Giuliano F . Research instruments for the diagnosis and treatment of patients with erectile dysfunction . Urology . 2006;68(suppl 3A):6–16
  7. Rosen RC , Cappelleri JC , Gendrano N . The International Index of Erectile Function (IIEF): a state-of-the-science review . Int J Impot Res . 2002;14:226–244
  8. Boolell M , Allen MJ , Ballard SA , et al.   Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction . Int J Impot Res . 1996;8:47–52
  9. Boolell M , Gepi-Attee S , Gingell JC , et al.   Sildenafil, a novel effective oral therapy for male erectile dysfunction . Br J Urol . 1996;78:257–261
  10. Eardley I , Ellis P , Boolell M , et al.   Onset and duration of action of sildenafil citrate for the treatment of erectile dysfunction . Br J Clin Pharmacol . 2002;53:61S–65S
  11. Gingell C , Sultana S , Hodgson G , et al.   Duration of action of sildenafil citrate in men with erectile dysfunction . J Sex Med . 2004;1:179–184
  12. Cappelleri JC , Rosen RC , Smith MD , et al.   Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function . Urology . 1999;54:346–351
  13. Boulton AJ , Selam JL , Sweeney M , et al.   Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus . Diabetologia . 2001;44:1296–1301
  14. Cappelleri JC , Siegel RL , Osterloh IH , et al.   Relationship between patient self-assessment of erectile function and the erectile function domain of the international index of erectile function . Urology . 2000;56:477–481
  15. Data on file . New York, NY: Pfizer Inc; 2005;
  16. DeBusk RF , Pepine CJ , Glasser DB , et al.   Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease . Am J Cardiol . 2004;93:147–153
  17. Dinsmore WW , Hodges M , Hargreaves C , et al.   Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects . [published correction appears in Urology 53: 1072] Urology . 1999;53:800–805
  18. Glina S , Bertero E , Claro J , et al.   Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction in Brazilian and Mexican men . Int J Impot Res . 2002;14(suppl 2):S27–S32
  19. Glina S , Bertero E , Claro J , et al.   Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in Latin America . Braz J Urol . 2001;27:148–154
  20. Goldstein I , Lue TF , Padma-Nathan H , et al.   Oral sildenafil in the treatment of erectile dysfunction . N Engl J Med . 1998;338:1397–1404
  21. Katz SD , Parker JD , Glasser DB , et al.   Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure . Am J Cardiol . 2005;95:36–42
  22. Kongkanand A , Ratana-Olarn K , Ruangdilokrat S , et al.   The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study . J Med Assoc Thai . 2003;86:195–205
  23. Levinson IP , Khalaf IM , Shaeer KZ , et al.   Efficacy and safety of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa . Int J Impot Res . 2003;15(suppl 1):S25–S29
  24. Lewis R , Bennett CJ , Borkon WD , et al.   Patient and partner satisfaction with VIAGRA (sildenafil citrate) treatment as determined by the erectile dysfunction inventory of treatment satisfaction questionnaire . Urology . 2001;57:960–965
  25. Olsson AM , Persson CA . Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in men with cardiovascular disease . Int J Clin Pract . 2001;55:171–176
  26. Padma-Nathan H , Steers WD , Wicker PA , et al.   Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients . Int J Clin Pract . 1998;52:375–380
  27. Pickering TG , Shepherd AM , Puddey IB , et al.   Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial . Am J Hypertens . 2004;17:1135–1142
  28. Rendell MS , Rajfer J , Wicker PA , et al.   Sildenafil for treatment of erectile dysfunction in men with diabetes . JAMA . 1999;281:421–426
  29. Seidman SN , Roose SP , Menza MA , et al.   Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate . Am J Psychiatry . 2001;158:1623–1630
  30. Stuckey BG , Jadzinsky MN , Murphy LJ , et al.   Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial . Diabetes Care . 2003;26:279–284
  31. Tan HM , Moh CL , Mendoza JB , et al.  The Assess-1 Study Group   Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction . Urology . 2000;56:635–640
  32. Tignol J , Furlan PM , Gomez-Beneyto M , et al.   Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression . Int Clin Psychopharmacol . 2004;19:191–199
  33. Young JM , Bennett C , Gilhooly P , et al.   Efficacy and safety of sildenafil citrate (Viagra®) in black and Hispanic American men . Urology . 2002;60:39–48
  34. Padma-Nathan H . Oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction: assessment of erections hard enough for sexual intercourse . Int J Clin Pract . 1999;102:13–15
  35. Carson C , Giuliano F , Goldstein I , et al.   The ‘effectiveness’ scale—therapeutic outcome of pharmacologic therapies for ED: an international consensus panel report . Int J Impot Res . 2004;16:207–213
  36. Padma-Nathan H , Stecher VJ , Sweeney M , et al.   Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial . Urology . 2003;62:400–403
  37. NIH Consensus Development Panel on Impotence NIH Consensus Conference . Impotence . JAMA . 1993;270:83–90

PII: S0090-4295(06)00767-9

doi: 10.1016/j.urology.2006.05.041

Urology
Volume 68, Issue 3, Supplement , Pages 17-25 , September 2006

Article Tools

* Image Usage & Resolution